Stanley Cohen discusses the latest findings from the trial looking at methotrexate withdrawal in patients with rheumatoid arthritis achieving low disease activity with tofacitinib (2:11).
14-06-2019 | Rheumatoid arthritis | EULAR 2019 | Article
Stanley Cohen discusses the latest findings from the trial looking at methotrexate withdrawal in patients with rheumatoid arthritis achieving low disease activity with tofacitinib (2:11).